You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for CHLORDIAZEPOXIDE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CHLORDIAZEPOXIDE

Average Pharmacy Cost for CHLORDIAZEPOXIDE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CHLORDIAZEPOXIDE 10 MG CAPSULE 42806-0562-01 0.13565 EACH 2025-04-23
CHLORDIAZEPOXIDE 10 MG CAPSULE 00555-0033-05 0.13565 EACH 2025-04-23
CHLORDIAZEPOXIDE-CLIDINIUM CAP 70700-0185-01 0.30098 EACH 2025-04-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for CHLORDIAZEPOXIDE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CHLORDIAZEPOXIDE HCL 5MG/CLIDINIUM BR 2.5MG C Golden State Medical Supply, Inc. 67877-0731-01 100 26.06 0.26060 EACH 2023-11-10 - 2028-06-14 FSS
CHLORDIAZEPOXIDE HCL 5MG/CLIDINIUM BR 2.5MG C Bryant Ranch PrePack DBA Bryant Ranch PrePack 72162-1917-01 100 295.48 2.95480 EACH 2024-03-08 - 2025-04-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Chlordiazepoxide Market Analysis and Price Projections

Introduction to Chlordiazepoxide

Chlordiazepoxide, a member of the benzodiazepine class, is widely used for managing anxiety disorders and alcohol withdrawal symptoms. Its therapeutic efficacy stems from enhancing the activity of neurotransmitters in the brain, inducing a calming effect. Here, we delve into the market analysis, growth drivers, challenges, and price projections for chlordiazepoxide.

Market Size and Growth

The global benzodiazepine drugs market, which includes chlordiazepoxide, is expected to experience significant growth. By 2032, the market is projected to reach USD 4 billion, growing at a CAGR of 3.9% from 2023[3].

Key Drivers of Market Growth

  • Increasing Prevalence of Anxiety Disorders: The rising incidence of anxiety disorders and insomnia worldwide is a primary driver. For instance, an estimated 31.1% of U.S. adults experience some form of anxiety disorder at some time in their lives[3].
  • Aging Population: Older adults are more susceptible to anxiety and sleep disorders, leading to higher prescription rates of benzodiazepines[3].
  • Growing Mental Health Awareness: Increased awareness and acceptance of pharmacological interventions for mental health conditions contribute to market growth[3].

Therapeutic Applications

Chlordiazepoxide is primarily used for:

  • Alcohol Withdrawal: It is a standard treatment for managing symptoms associated with alcohol withdrawal.
  • Anxiety Management: It is effective in reducing anxiety levels in patients.
  • Preoperative Anxiety: It is sometimes used to manage anxiety before surgical procedures[1].

Market Segmentation

End Users

The market is segmented by end users such as clinics, home care settings, and hospitals. Hospitals are expected to hold a significant share due to the high volume of prescriptions and treatments conducted within these settings[1].

Distribution Channels

The market is also segmented by distribution channels, including hospital pharmacies, retail drug stores, and online pharmacies. Hospital pharmacies are anticipated to be valued at USD 2.1 billion by 2032[3].

Market Challenges and Restraints

Despite the growth potential, several challenges affect the market:

  • Regulatory Controls: Strict regulations regarding benzodiazepine prescriptions due to their potential for abuse and dependency[1].
  • Safety Concerns: Potential side effects and the risk of substance dependency are significant restraints[1].
  • Competition from Newer Anxiolytics: Growing competition from newer anxiolytics with better safety profiles poses a challenge to the market[1].

Market Opportunities

Several opportunities exist for growth and innovation:

  • Expanding Mental Health Awareness: Increasing awareness about mental health treatments can drive demand for chlordiazepoxide.
  • Telemedicine Integration: The integration of telemedicine can increase access to psychiatric consultations, thereby boosting the market[1].
  • Emerging Markets: Growing healthcare expenditure in emerging markets presents untapped potential for chlordiazepoxide tablets[1].

Price Projections and Cost Analysis

Current Pricing

The cost of chlordiazepoxide varies based on dosage and quantity. For example:

  • A supply of 60 chlordiazepoxide 5 mg oral capsules can cost around $16.27, with a per-unit price of $0.27[2].
  • A supply of 3 chlordiazepoxide 25 mg oral capsules can cost around $9.82, with a per-unit price of $3.27[2].

Price Trends

Prices are expected to remain relatively stable due to the competitive nature of the market and the availability of generic versions. However, factors such as stock shortages and regulatory changes can influence pricing.

Regional Pricing Variations

Prices can vary significantly across different regions. For instance, North America, which held a market share of 41.8% in 2023, is expected to continue as a major market, influencing global pricing trends[3].

Competitive Landscape

The market is characterized by the presence of established pharmaceutical companies such as Novartis AG, GlaxoSmithKline plc, Pfizer Inc., and Roche. These companies adopt various strategic initiatives like collaboration, global expansion, and research and development to maintain their market share[3].

Innovations and Product Development

To stay competitive, companies are focusing on:

  • Research and Development: Developing formulations with improved safety and efficacy.
  • Patient-Centric Drug Delivery Systems: Implementing personalized treatment approaches using big data and AI analytics.
  • Non-Addictive Alternatives: Innovating non-addictive alternatives or adjunct therapies to enhance the efficacy of chlordiazepoxide[1].
"Organizations are recommended to focus on research to develop formulations with improved safety and efficacy, patient-centric drug delivery systems, and personalized treatment approaches leveraging big data and AI analytics to identify and predict patient needs more accurately."[1]

Key Takeaways

  • The global benzodiazepine drugs market, including chlordiazepoxide, is expected to grow significantly due to increasing anxiety disorders and an aging population.
  • The market faces challenges such as regulatory controls, safety concerns, and competition from newer anxiolytics.
  • Opportunities exist in expanding mental health awareness, telemedicine integration, and emerging markets.
  • Prices are expected to remain relatively stable, with variations based on region and availability.
  • The competitive landscape is dominated by established pharmaceutical companies focusing on innovation and personalized treatment approaches.

FAQs

What are the primary therapeutic applications of chlordiazepoxide?

Chlordiazepoxide is primarily used for managing alcohol withdrawal symptoms, anxiety disorders, and preoperative anxiety.

What are the key drivers of the chlordiazepoxide market growth?

The key drivers include the increasing prevalence of anxiety disorders, an aging population, and growing mental health awareness.

What are the major challenges facing the chlordiazepoxide market?

Major challenges include strict regulatory controls, potential side effects, risk of substance dependency, and competition from newer anxiolytics.

How does the competitive landscape of the chlordiazepoxide market look?

The market is competitive, with established pharmaceutical companies like Novartis AG, GlaxoSmithKline plc, Pfizer Inc., and Roche vying for market share through strategic initiatives.

What are the price trends for chlordiazepoxide?

Prices are expected to remain relatively stable, influenced by factors such as stock shortages and regulatory changes, with variations based on region and availability.

What innovations are being pursued in the chlordiazepoxide market?

Companies are focusing on developing formulations with improved safety and efficacy, patient-centric drug delivery systems, and personalized treatment approaches using big data and AI analytics.

Sources

  1. 360iResearch: Chlordiazepoxide Tablets Market Size & Share 2025-2030.
  2. Drugs.com: Chlordiazepoxide Prices, Coupons, Copay Cards & Patient Assistance.
  3. Grand View Insights: Benzodiazepine Drugs Market Size & Share | Growth Forecasts 2032.
  4. Grand View Research: Benzodiazepine Drugs Market Size And Share Report, 2030.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.